US$ 26.51
glp-1 pregnancy From JAMA: #GLP-1 receptor agonist exposure with discontinuation before or during early #pregnancy was associated with greater gestational weight gain and increased risk of preterm delivery, gestational #diabetes, and hypertensive disorders. https://ja GLP-1 Receptor Agonists in Pregnancy
Description
Ozempic/semaglutide is the one thats been all over the news lately, but look for mounjaro/tirzepatide coming down the pike

Avoid Excessively Rapid Weight Loss A slower, steady rate reduces the risk of Telogen Effluvium

Know that before you enroll
FDA approvals now encompass chronic kidney disease indications for some agents, obstructive sleep apnea treatment and metabolic dysfunction associated steatotic liver disease for select products

Elevate your trial success rate with the cutting-edge insights from Clival database
However, most report that these side effects go away after a few days or weeks
